☆ 4.7 Article

Identification of Distinct Clinical Phenotypes of Critically Ill COVID-19 Patients: Results from a Cohort Observational Study

JOURNAL OF CLINICAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Critical Care Medicine

Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis

Sander Siepel et al.

Summary: By analyzing granular data from 3202 adult COVID patients in Dutch ICUs, researchers identified significant clinical heterogeneity in COVID-19 patients, which is predominantly driven by inflammation and dead space ventilation. Only a small percentage of patients remained in the same clinical phenotype throughout the 21-day intensive care treatment. Rating: 8 points.

JOURNAL OF INTENSIVE CARE MEDICINE (2023)

Add to Collection

Article Infectious Diseases

High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department

Kirby Tong-Minh et al.

Summary: High PCT levels are associated with a high incidence of severe COVID-19 infections in patients presenting at the emergency department. Routine measurement of PCT in COVID-19 patients in the ED can assist physicians in making clinical decisions regarding ICU admissions.

BMC INFECTIOUS DISEASES (2022)

Add to Collection

Review Respiratory System

Tocilizumab for COVID-19: A systematic review and meta-analysis of randomized controlled trials

Tarun Krishna Boppana et al.

Summary: Effective treatment modalities are needed for severe COVID-19 cases. This meta-analysis demonstrates that the use of tocilizumab did not reduce all-cause mortality in COVID-19 patients, but it reduced the need for ICU admission and showed a higher risk of secondary infections.

MONALDI ARCHIVES FOR CHEST DISEASE (2022)

Add to Collection

Review Medical Laboratory Technology

Serum biomarkers for prediction of mortality in patients with COVID-19

Rohit S. Loomba et al.

Summary: This study found significant differences in biomarker levels on admission in COVID-19 patients who survived compared to those who did not. Biomarkers such as white blood cell count, C-reactive protein, procalcitonin, ferritin, D-dimer were noted to be significantly higher in patients who died, while lymphocyte count, platelet count and albumin were significantly lower. Further research is needed to develop risk stratification models for judicious use of healthcare resources.

ANNALS OF CLINICAL BIOCHEMISTRY (2022)

Add to Collection

Article Infectious Diseases

The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patients

Cher Wei Twe et al.

Summary: This study aimed to determine the optimal cut-off value of serum procalcitonin (PCT) in predicting important clinical outcomes, such as mechanical ventilation and all-cause mortality, among moderate to severe COVID-19 patients. The results showed that a PCT level of 0.2 ng/mL was associated with an elevated risk in all-cause mortality, the need for non-invasive ventilation, and a longer duration of mechanical ventilation.

BMC INFECTIOUS DISEASES (2022)

Add to Collection

Article Respiratory System

Mortality Predictive Value of APACHE II and SOFA Scores in COVID-19 Patients in the Intensive Care Unit

Mohammad Taghi Beigmohammadi et al.

Summary: This study evaluated the mortality predictive value of APACHE II and SOFA scores in critically ill COVID-19 patients. The results showed that daily SOFA scoring performed better in predicting mortality, but with limitations in accuracy. New scoring methods are needed to consider prognostic factors and daily evaluation of clinical condition changes.

CANADIAN RESPIRATORY JOURNAL (2022)

Add to Collection

Editorial Material Biochemical Research Methods

Mass versus personalized medicine against COVID-19 in the system sciences era

Laura Teodori et al.

Summary: The importance of personalized/precision medicine for targeted therapies against SARS-CoV-2 is discussed, highlighting its potential for improved efficacy and safety in healthcare.

CYTOMETRY PART A (2022)

Add to Collection

Article Multidisciplinary Sciences

Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19

Paul W. Blair et al.

Summary: This study explored the associations between clinical phenotypes of COVID-19 and the host inflammatory response. It identified three distinct inflammatory biomarker clusters that were associated with differences in disease severity, age, BMI, and CCI. These findings suggest that inflammatory patterns can help stratify COVID-19 patients and predict comorbid disease and severe illness due to COVID-19.

SCIENTIFIC REPORTS (2022)

Add to Collection

Editorial Material Critical Care Medicine

Personalized medicine in COVID-19

Lieke Bakkerus et al.

INTENSIVE CARE MEDICINE (2022)

Add to Collection

Article Critical Care Medicine

Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial

M. Fish et al.

Summary: This study identified three subphenotypes of COVID-19, with different treatment responses to ABO-compatible convalescent plasma therapy in critically ill patients. Differences in subphenotype prevalence between randomized clinical trial populations may explain the inconsistent results of COVID-19 immunotherapies.

INTENSIVE CARE MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19

Nicolas de Prost et al.

Summary: In this prospective study, it was found that the clinical phenotype of patients infected with the Omicron variant differs from those infected with the Delta variant. Immunocompromised patients infected with the Omicron variant have a significantly higher mortality rate compared to non-immunocompromised patients. However, no association was observed between specific sublineages or viral genome polymorphisms/mutational profiles of the Omicron variant and mortality.

NATURE COMMUNICATIONS (2022)

Add to Collection

Editorial Material Critical Care Medicine

Immunomodulators in Mechanically Ventilated Patients With COVID-19: Lessons Learned From Underpowered Trials

Carlos A. Gomez et al.

CRITICAL CARE MEDICINE (2022)

Add to Collection

Article Critical Care Medicine

Clinical sepsis phenotypes in critically ill COVID-19 patients

Niklas Bruse et al.

Summary: Classifying critically ill COVID-19 patients into clinical phenotypes may help with prognostication, treatment efficacy prediction, and personalized medicine. The distribution of phenotypes was similar between COVID-19 and non-COVID-19 viral pneumonia sepsis cohorts, with a higher proportion of patients with the delta-phenotype in bacterial sepsis cohorts. The introduction of dexamethasone treatment was associated with an increased proportion of patients with the delta-phenotype and improved survival.

CRITICAL CARE (2022)

Add to Collection

Article Respiratory System

Mortality Predictive Value of APACHE II and SOFA Scores in COVID-19 Patients in the Intensive Care Unit

Mohammad Taghi Beigmohammadi et al.

Summary: A study on 204 critically ill COVID-19 patients found that the daily SOFA score was a better predictor of mortality than APACHE II. However, both scores were not highly accurate in predicting death, indicating the need for new scoring systems to assess clinical conditions.

CANADIAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Large-Scale Multi-omic Analysis of COVID-19 Severity

Katherine A. Overmyer et al.

Summary: The study conducted RNA-seq and high-resolution mass spectrometry on blood samples from COVID-19-positive and COVID-19-negative patients, identifying molecular features associated with disease severity and outcomes, offering pathophysiological insights and therapeutic suggestions. The observed dysregulation of platelet function, blood coagulation, acute phase response, and endotheliopathy further illuminated the unique COVID-19 phenotype. The findings are presented through a web-based tool enabling interactive exploration and machine learning prediction of COVID-19 severity.

CELL SYSTEMS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

C-reactive protein and clinical outcomes in patients with COVID-19

Nathaniel R. Smilowitz et al.

Summary: Elevated CRP levels at initial hospital presentation in COVID-19 patients are associated with an increased risk of venous thromboembolism, acute kidney injury, critical illness, and mortality. There is a dose-response relationship between CRP concentration and adverse outcomes, with patients with high levels of both CRP and D-dimer showing the greatest risk of adverse outcomes. Systemic inflammation, as measured by CRP, plays a significant role in predicting clinical outcomes in COVID-19.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Editorial Material Genetics & Heredity

Is precision medicine relevant in the age of COVID-19?

Amy Zhou et al.

GENETICS IN MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

ROLE OF BIOCHEMICAL MARKERS IN THE MONITORING OF COVID-19 PATIENTS

Pablo Letelier et al.

Summary: COVID-19, caused by the SARS-CoV-2 virus, has diverse clinical characteristics ranging from asymptomatic infection to severe pneumonia. Various laboratory parameters change in these patients, serving as biomarkers to assess disease progression and severity. This review analyzes altered biochemical and immunological markers in COVID-19 patients and their impact on different organs, along with inflammatory markers and their implications in disease evolution.

JOURNAL OF MEDICAL BIOCHEMISTRY (2021)

Add to Collection

Article Medicine, General & Internal

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama et al.

Summary: Among hospitalized patients with Covid-19 pneumonia not on mechanical ventilation, tocilizumab reduced the risk of progression to mechanical ventilation or death, but did not improve overall survival. There were no new safety concerns identified.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients

Lili Li et al.

Summary: The study identified IL-8 as a biomarker to predict disease severity and prognosis of COVID-19 patients, showing that IL-8 is more distinct for mild cases compared to IL-6.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

COVID-19 Clinical Phenotypes: Presentation and Temporal Progression of Disease in a Cohort of Hospitalized Adults in Georgia, United States

Juliana F. da Silva et al.

Summary: This retrospective study analyzed data from 305 hospitalized COVID-19 patients, identifying a severe phenotype with high mortality and poor prognosis, characterized by specific clinical features. Further validation in other cohorts is necessary to better understand clinical phenotypes and risk factors for tailored clinical management of COVID-19.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Review Pharmacology & Pharmacy

Personalized therapy: can it tame the COVID-19 monster?

Mohd Arish et al.

Summary: Due to variations in genetic determinants, sex, age, and ethnic background, the therapeutic efficacy and toxicity of COVID-2019 therapy may differ. Therefore, personalized therapy based on biomarkers could be more suitable.

PERSONALIZED MEDICINE (2021)

Add to Collection

Article Immunology

High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19

Aiping Ma et al.

Summary: The study found a positive association between the duration of illness in patients with severe COVID-19 and serum levels of IL-8 and soluble IL-2R alpha, indicating the involvement of neutrophils and T cells in the evolution of COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Precision Medicine for COVID-19 Phenotype Anarchy or Promise Realized?

Kimberley DeMerle et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles

Elizabeth R. Lusczek et al.

Summary: This study identified three clinical phenotypes of COVID-19, reflecting different patient populations with varying comorbidities, complications, and clinical outcomes. Further research is needed to determine the utility of these phenotypes in clinical practice and trial design.

PLOS ONE (2021)

Add to Collection

Article Medicine, General & Internal

Tocilizumab in the treatment of COVID-19-a meta-analysis

T. Avni et al.

Summary: Interleukin-6 inhibitor tocilizumab reduces 28-30 days all-cause mortality, mechanical ventilation risk, ICU admission rate, and superinfection risk in COVID-19 patients. However, no mortality benefit was found in critically ill patients and those who were predominantly treated with steroids. Further research is needed to determine sub-groups that benefit most and the optimal timing of TCZ administration in severe COVID-19.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)

Add to Collection

Review Environmental Sciences

Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic

Naim Mahroum et al.

Summary: Tocilizumab shows potential efficacy in severe COVID-19, especially in reducing mortality rates and preventing ICU admissions, according to a systematic review and meta-analysis. However, the risk of infection may increase when combined with corticosteroid therapy.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Add to Collection

Article Respiratory System

COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy

Andrea Portacci et al.

Summary: According to this study, patients in the second wave of the COVID-19 pandemic were younger, had fewer concomitant chronic conditions, and presented with milder clinical symptoms. Patients in the second wave had better short-term clinical outcomes, with lower death rates and more transfers to general wards.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)

Add to Collection

Review Health Care Sciences & Services

Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System

Joaquin Dopazo et al.

Summary: Personalized medicine plays a crucial role in studying and treating the COVID-19 pandemic, helping to develop individualized prevention and treatment strategies, improve the accuracy of clinical decision-making, and better control the epidemic.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

C-reactive protein levels associated with COVID-19 outcomes in the United States

Jacob Lentner et al.

Summary: This study revealed a positive correlation between CRP levels of COVID-19 patients and their outcomes in terms of mortality and length of stay (LoS). The first CRP level was a significant predictor for mortality and LoS, indicating that higher CRP levels were associated with increased odds of death and longer hospital stays.

JOURNAL OF OSTEOPATHIC MEDICINE (2021)

Add to Collection

Review Medicine, General & Internal

Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis

Preeti Malik et al.

Summary: This study found a significant association between lymphopenia, thrombocytopenia, and elevated levels of CRP, PCT, LDH, D-dimer, and COVID-19 severity. These results have the potential to be used as early biomarkers to improve the management of COVID-19 patients by identifying high-risk patients and allocating healthcare resources appropriately in the pandemic.

BMJ EVIDENCE-BASED MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain

Alejandro Rodriguez et al.

Summary: The study identified three clinical phenotypes that significantly correlated with host-response patterns and ICU mortality using a machine learning model, showing different risk factors across the whole population and clinical phenotypes, which may limit the application of a one-size-fits-all model in practice.

CRITICAL CARE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

C-reactive protein and clinical outcomes in patients with COVID-19

Nathaniel R. Smilowitz et al.

Summary: Elevated CRP levels upon hospital admission in COVID-19 patients are associated with increased risks of VTE, AKI, critical illness, and mortality, suggesting a crucial role of systemic inflammation in the clinical course of COVID-19.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medical Laboratory Technology

The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks

Giuseppe Lippi et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Add to Collection

Letter Critical Care Medicine

Clinical phenotypes of critically ill COVID-19 patients

Elie Azoulay et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Editorial Material Critical Care Medicine

COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Luciano Gattinoni et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Letter Virology

Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19

Nurshad Ali

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Geriatrics & Gerontology

The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects

Clara Bonanad et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)

Add to Collection

Article Critical Care Medicine

Characterization of the Inflammatory Response to Severe COVID-19 Illness

Oliver J. McElvaney et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Add to Collection

Review Cell Biology

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts

Jin Wang et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Carolina Lucas et al.

NATURE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

An inflammatory cytokine signature predicts COVID-19 severity and survival

Diane Marie Del Valle et al.

NATURE MEDICINE (2020)

Add to Collection

Review Critical Care Medicine

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

Daniel E. Leisman et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Yapeng Su et al.

CELL (2020)

Add to Collection

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Critical Care Medicine

A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality

Philip van der Zee et al.

CRITICAL CARE (2020)

Add to Collection

Article Respiratory System

Five novel clinical phenotypes for critically ill patients with mechanical ventilation in intensive care units: a retrospective and multi database study

Longxiang Su et al.

RESPIRATORY RESEARCH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Efficient Bayesian estimates for discrimination among topologically different systems biology models

David R. Hagen et al.

MOLECULAR BIOSYSTEMS (2015)

Add to Collection

© Peeref 2019-2024. All rights reserved.